Prudential Financial Inc Halozyme Therapeutics, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 230,563 shares of HALO stock, worth $10.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
230,563
Previous 180,671 27.61%
Holding current value
$10.9 Million
Previous $9.46 Million 39.44%
% of portfolio
0.02%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$51.3 - $64.42 $2.56 Million - $3.21 Million
49,892 Added 27.61%
230,563 $13.2 Million
Q2 2024

Aug 13, 2024
SELL
$37.81 - $52.4 $1.61 Million - $2.23 Million
-42,534 Reduced 19.06%
180,671 $9.46 Million
Q1 2024

May 14, 2024
BUY
$33.68 - $41.95 $2.88 Million - $3.59 Million
85,465 Added 62.05%
223,205 $9.08 Million
Q4 2023

Feb 13, 2024
BUY
$33.32 - $42.1 $3.17 Million - $4 Million
95,128 Added 223.24%
137,740 $5.09 Million
Q3 2023

Nov 13, 2023
BUY
$36.46 - $44.03 $807,370 - $975,000
22,144 Added 108.19%
42,612 $1.63 Million
Q2 2023

Aug 11, 2023
SELL
$30.28 - $38.74 $62,740 - $80,269
-2,072 Reduced 9.19%
20,468 $738,000
Q1 2023

May 12, 2023
BUY
$32.86 - $55.7 $11,040 - $18,715
336 Added 1.51%
22,540 $860,000
Q4 2022

Feb 14, 2023
SELL
$40.06 - $59.44 $908,240 - $1.35 Million
-22,672 Reduced 50.52%
22,204 $0
Q3 2022

Nov 04, 2022
SELL
$38.53 - $51.78 $10.4 Million - $14 Million
-270,353 Reduced 85.76%
44,876 $1.78 Million
Q2 2022

Aug 15, 2022
BUY
$37.35 - $48.3 $8.59 Million - $11.1 Million
229,934 Added 269.58%
315,229 $13.9 Million
Q1 2022

May 13, 2022
SELL
$31.97 - $41.06 $798,898 - $1.03 Million
-24,989 Reduced 22.66%
85,295 $3.4 Million
Q4 2021

Feb 14, 2022
SELL
$31.82 - $40.75 $29,910 - $38,305
-940 Reduced 0.85%
110,284 $4.44 Million
Q3 2021

Nov 15, 2021
BUY
$38.47 - $46.42 $1.22 Million - $1.47 Million
31,607 Added 39.7%
111,224 $4.53 Million
Q2 2021

Aug 16, 2021
BUY
$38.84 - $51.31 $1.57 Million - $2.07 Million
40,331 Added 102.66%
79,617 $3.62 Million
Q1 2021

May 12, 2021
SELL
$39.51 - $51.45 $9.56 Million - $12.4 Million
-241,958 Reduced 86.03%
39,286 $1.64 Million
Q4 2020

Feb 16, 2021
BUY
$25.81 - $43.62 $7.17 Million - $12.1 Million
277,958 Added 8458.86%
281,244 $12 Million
Q3 2020

Aug 05, 2021
SELL
$25.74 - $29.63 $4.01 Million - $4.62 Million
-155,901 Reduced 97.94%
3,286 $86,000
Q3 2020

Nov 16, 2020
BUY
$25.74 - $29.63 $4.08 Million - $4.7 Million
158,559 Added 25248.25%
159,187 $4.18 Million
Q2 2020

Aug 05, 2021
SELL
$16.25 - $26.81 $5.57 Million - $9.19 Million
-342,889 Reduced 99.82%
628 $17,000
Q2 2020

Aug 12, 2020
BUY
$16.25 - $26.81 $5.58 Million - $9.2 Million
343,279 Added 144234.88%
343,517 $9.21 Million
Q1 2020

Aug 05, 2021
SELL
$13.9 - $21.83 $6.16 Million - $9.68 Million
-443,489 Reduced 99.95%
238 $4,000
Q1 2020

May 12, 2020
BUY
$13.9 - $21.83 $6.16 Million - $9.68 Million
443,494 Added 190340.77%
443,727 $7.98 Million
Q4 2019

Aug 05, 2021
SELL
$14.93 - $19.53 $5.24 Million - $6.86 Million
-351,057 Reduced 99.93%
233 $4,000
Q4 2019

Feb 11, 2020
BUY
$14.93 - $19.53 $5.24 Million - $6.86 Million
351,057 Added 150668.23%
351,290 $6.23 Million
Q3 2019

Aug 05, 2021
SELL
$15.2 - $17.69 $393,710 - $458,206
-25,902 Reduced 99.11%
233 $4,000
Q3 2019

Nov 13, 2019
BUY
$15.2 - $17.69 $143,168 - $166,622
9,419 Added 56.35%
26,135 $405,000
Q2 2019

Aug 08, 2019
BUY
$14.75 - $17.26 $55,312 - $64,725
3,750 Added 28.92%
16,716 $0
Q1 2019

May 15, 2019
BUY
$13.94 - $17.58 $2,230 - $2,812
160 Added 1.25%
12,966 $0
Q4 2018

Feb 07, 2019
SELL
$13.33 - $18.66 $4.27 Million - $5.97 Million
-320,076 Reduced 96.15%
12,806 $187,000
Q3 2018

Nov 07, 2018
SELL
$16.68 - $18.41 $12.7 Million - $14 Million
-760,248 Reduced 69.55%
332,882 $0
Q2 2018

Aug 13, 2018
SELL
$16.87 - $20.3 $5.1 Million - $6.13 Million
-302,060 Reduced 21.65%
1,093,130 $0
Q1 2018

May 04, 2018
BUY
$17.06 - $21.2 $8.29 Million - $10.3 Million
485,904 Added 53.44%
1,395,190 $0
Q4 2017

Feb 13, 2018
BUY
$16.75 - $20.8 $15 Million - $18.6 Million
896,610 Added 7073.29%
909,286 $18.4 Million
Q3 2017

Nov 02, 2017
BUY
$11.76 - $17.4 $149,069 - $220,562
12,676
12,676 $220,000

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email